By

WATCH THE REPLAY Cannabis Social Equity programs are designed to address and remedy the disparate long-term impact of federal and state enforcement policies on certain communities and to support equal opportunity in the industry, with the goal of creating employment and ownership...

WATCH THE REPLAY Our panel of experts will discuss the drivers and outlook for current wave of M&A activity, E&M valuations, industry sub-verticals, SPACs, future prospects for independent film and television production companies, regulatory concerns and risk mitigation...

WATCH THE REPLAY Healthcare companies and financial investors use M&A to enter new markets and grow amid increasing competition, technological imperatives and changing industry paradigm.  Behavioral health M&A has become one of the most active sectors in health...

WATCH THE REPLAY Our panel of experts will examine current trends in M&A and shareholder activism, including ESG as part of the deal process, post-pandemic developments in corporate governance, new imperatives for transactional due diligence (MeeToo, cyber, other), relevant...

WATCH THE REPLAY The panel will discuss personal and corporate exit planning, estate and wealth planning, transfer alternatives (sale, ESOP, family) self-diligence and due diligence, transactional process, importance of valuation, and anticipated tax changes.  We will...

WATCH THE REPLAY The pandemic has caused a tremendous stress in the healthcare industry, accelerating change and growth in many sectors while causing financial distress and need for restructuring in others. The evolving industry paradigm is attracting capital and investor...

WATCH THE REPLAY Our panel of experts will examine current litigation trends in the Cannabis industry, including shareholder disputes, social equity, branding and intellectual property.  We will address Cannabis-specific issues, valuation, arbitration v. litigation...

WATCH THE REPLAY While the pandemic renewed the investor focus on healthcare, physician medical group M&A continues to be a very robust market in 2021, with nearly three-quarters of transactions driven by private equity firms and non-healthcare acquirers. As the healthcare...

REGISTER COMPLIMENTARY / SUBMIT PRELIMINARY QUESTIONS TO THE PANEL HERE